SNTI

SNTI

USD

Senti Biosciences Inc. Common Stock

$1.810-0.110 (-5.729%)

Reaalajas hind

Healthcare
Biotehnoloogia
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$1.920

Kõrge

$2.020

Madal

$1.800

Maht

0.05M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

47.3M

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

0.19M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $1.26Praegune $1.810Kõrge $16.94

Seotud uudised

GlobeNewswire

Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025

Two presentations, including one oral session, build on existing data and show deep and durable clinical remission rates, combined with a strong safety profile, for SENTI-202 in treating relapsed/refractory Acute Myeloid

Vaata rohkem
Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025
Analyst Upgrades

HC Wainwright & Co. Initiates Coverage On Senti Biosciences with Buy Rating, Announces Price Target of $12

HC Wainwright & Co. analyst Emily Bodnar initiates coverage on Senti Biosciences with a Buy rating and announces Price Target of $12.

Vaata rohkem
HC Wainwright & Co. Initiates Coverage On Senti Biosciences with Buy Rating, Announces Price Target of $12

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.